Non-Canonical, Strongly Selective Protein Disulfide Isomerases as Anticancer Therapeutic Targets

Protein Disulfide Isomerases (PDIs) are emerging targets in anticancer therapy, with several PDI inhibitors demonstrating anticancer efficacy in preclinical models. Research has largely focused on “canonical” PDIs, such as PDIA1, which contain CXXC active site motifs where C represents Cysteine. Can...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Mary E. Law, Zaafir M. Dulloo, Brian Hardy, Ania Kelegama, Reagan Clark, Mariana Rivas Montbrun, Gabriella Antmann, Srihith Nooka, Ronald K. Castellano, Brian K. Law
Format:	Artigo
Sprog:	Inglês
Udgivet:	MDPI AG 2025-08-01
Serier:	Biomolecules
Fag:	protein disulfide isomerases PDIA1 AGR2 AGR3 ERp44
Online adgang:	https://www.mdpi.com/2218-273X/15/8/1146
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!